• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.

作者信息

Blitzer J B, Granfortuna J M, Gottlieb A J, Smith J R, Theodorakis M E, Zamkoff K W, Landaw S A, Goldberg J, Scalzo A J, Lamberson H

出版信息

Am J Hematol. 1987 Apr;24(4):329-39. doi: 10.1002/ajh.2830240402.

DOI:10.1002/ajh.2830240402
PMID:3565371
Abstract

Twenty-one episodes of thrombotic thrombocytopenic purpura (TTP) were treated with plasmapheresis. Adjunctive agents included corticosteroids, aspirin, dipyridamole, and vincristine. There were 17 patients; 12 were female. The median age was 41 years. Most patients presented with neurologic symptoms. Thrombocytopenia was profound with a mean initial platelet count of 14,900/mm3. The mean hematocrit on presentation was 26.7% and the mean LDH 1300 IU/L. Eighteen episodes responded completely following plasmapheresis/plasma exchange (86%). Response was prompt, the initial rise in platelet count occurred after a mean of four exchanges, and complete response (a platelet count over 150,000/mm3) was obtained after a mean of nine exchanges. Four of the episodes treated were relapses that occurred in three patients. All responders are alive with a median duration of follow-up of 20 months. The three patients who failed to respond have died. This report extends recent observations that the addition of plasmapheresis/plasma exchange to the therapy of TTP has significantly improved the outlook for patients with this disorder.

摘要

相似文献

1
Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.
Am J Hematol. 1987 Apr;24(4):329-39. doi: 10.1002/ajh.2830240402.
2
Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis.
Am J Hematol. 1990 Sep;35(1):18-21. doi: 10.1002/ajh.2830350105.
3
Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents.血栓性血小板减少性紫癜:血浆置换与抗血小板药物联合治疗
Ann Intern Med. 1980 Feb;92(2 Pt 1):149-55. doi: 10.7326/0003-4819-92-2-149.
4
Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine.
Eur J Pediatr. 1994 Jul;153(7):517-9. doi: 10.1007/BF01957008.
5
Treatment of thrombotic thrombocytopenic purpura with combined exchange plasmapheresis and anti-platelet agents.联合置换血浆分离术和抗血小板药物治疗血栓性血小板减少性紫癜
Semin Thromb Hemost. 1981 Winter;7(1):37-42. doi: 10.1055/s-2007-1005068.
6
Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine.
Transfus Sci. 2000 Oct;23(2):101-6. doi: 10.1016/s0955-3886(00)00073-4.
7
Treatment of thrombotic thrombocytopenic purpura. Plasmapheresis, plasma transfusion, and vincristine.血栓性血小板减少性紫癜的治疗。血浆置换、血浆输注和长春新碱。
Arch Intern Med. 1986 Feb;146(2):266-7.
8
Thrombotic thrombocytopenic purpura.
Am Fam Physician. 1985 Feb;31(2):141-5.
9
Plasmapheresis with exchange as primary treatment for thrombotic thrombocytopenic purpura.以血浆置换联合置换作为血栓性血小板减少性紫癜的主要治疗方法。
Hawaii Med J. 1990 Feb;49(2):44, 46, 49-51.
10
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜
J Am Osteopath Assoc. 1989 Feb;89(2):199-202, 205.

引用本文的文献

1
Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura.美国三级医疗保健系统中使用卡普拉珠单抗治疗免疫性血栓性血小板减少性紫癜患者的初步经验。
Ann Hematol. 2024 Nov;103(11):4449-4457. doi: 10.1007/s00277-024-05993-5. Epub 2024 Sep 11.
2
[Not Available].[无可用内容]。
Tunis Med. 2024 Jun 5;102(6):343-347. doi: 10.62438/tunismed.v102i6.4614.
3
Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.
美国免疫介导性血栓性血小板减少性紫癜患者的流行病学、治疗模式、临床结局及疾病负担
Res Pract Thromb Haemost. 2022 Sep 16;6(6):e12802. doi: 10.1002/rth2.12802. eCollection 2022 Aug.
4
Active Hepatitis C Leading to Refractory Thrombotic Thrombocytopenic Purpura - A Dubious Association and The Challenges Faced in Management.活动性丙型肝炎导致难治性血栓性血小板减少性紫癜——一种可疑的关联及管理中面临的挑战
Cureus. 2019 Jul 16;11(7):e5147. doi: 10.7759/cureus.5147.
5
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience.长春新碱作为血栓性血小板减少性紫癜治疗性血浆置换的辅助治疗:单中心经验。
Balkan Med J. 2018 Nov 15;35(6):417-421. doi: 10.4274/balkanmedj.2017.1215. Epub 2018 Jul 3.
6
How I treat refractory thrombotic thrombocytopenic purpura.我如何治疗难治性血栓性血小板减少性紫癜。
Blood. 2015 Jun 18;125(25):3860-7. doi: 10.1182/blood-2014-11-551580. Epub 2015 Mar 17.
7
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange.血栓性血小板减少性紫癜/溶血性尿毒症综合征:预测血浆置换反应的因素的多变量分析
Ann Hematol. 1995 Jun;70(6):319-23. doi: 10.1007/BF01696619.
8
Thrombotic thrombocytopenic purpura with terminal pancytopenia.伴有终末期全血细胞减少的血栓性血小板减少性紫癜。
Postgrad Med J. 1990 Nov;66(781):955-7. doi: 10.1136/pgmj.66.781.955.
9
Glomerular fibrin deposition and removal.肾小球纤维蛋白沉积与清除
Pediatr Nephrol. 1990 Jan;4(1):78-87. doi: 10.1007/BF00858447.